Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03049982 · ClinicalTrials.gov registry record · NA
A Study for Obstructive Sleep Apnea Using a New At-Home Sleep Test
A NA study, sponsored by Zephyr Sleep Technologies.
- Completed
- Registry status
- NA
- Development phase
- 28
- Enrollment target
NCT03049982: Completed NA study, sponsored by Zephyr Sleep Technologies.
NCT03049982 is a NA study that has completed, run by Zephyr Sleep Technologies. The registered enrollment target is 28 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03049982, a NA study, has completed, sponsored by Zephyr Sleep Technologies.
- COMPLETED
- Registry status
- NA
- Development phase
- 28 participants
- Enrollment target
Study Summary
The purpose of the study is to test the workflow of an auto-titrating mandibular positioner in its intended setting. Participants with obstructive sleep apnea will use the device to determine their eligibility for oral appliance therapy and provide feedback on usability of the device.
Primary Outcome
Data for this outcome are largely directed at the study staff, not study participants. Data collected for this outcome include: time required to evaluate eligibility for device use, time required to prepare device for use.
Interventions
- DEVICE Auto-titrating mandibular positioner test
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 28 participants |
| Start Date | 2017-02-07 |
| Est. Completion | 2018-10-17 |
| Phase | NA |
What the finished NCT03049982 record still lists
NCT03049982 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 28 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 1 intervention - of which Auto-titrating mandibular positioner test is the first listed.
NCT03049982 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03049982 about?
NCT03049982 is a clinical study titled "A Study for Obstructive Sleep Apnea Using a New At-Home Sleep Test". The purpose of the study is to test the workflow of an auto-titrating mandibular positioner in its intended setting. Participants with obstructive sleep apnea will use the device to determine their eligibility for oral appliance therapy and provide feedback on usability of the device.
What is the current status of trial NCT03049982?
This trial is currently completed. It is a NA study. The enrollment target is 28 participants. The study started on 2017-02-07. Estimated completion is 2018-10-17.
What interventions are being tested in trial NCT03049982?
The interventions under investigation include: Auto-titrating mandibular positioner test (DEVICE).
Who is sponsoring clinical trial NCT03049982?
This trial is sponsored by Zephyr Sleep Technologies, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03049982's enrollment target sits among peer trials
28 1704th of 2000 higher than 293 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03471117 · 28 participants · Phase 4
Pioglitazone to Reduce Sympathetic Overactivity in CKD Patients
- NCT03523975 · 28 participants · Phase 1
Venetoclax, Lenalidomide and Rituximab in Patients With Previously Untreated Mantle Cell Lymphoma
- NCT03608631 · 28 participants · Phase 1
iExosomes in Treating Participants With Metastatic Pancreas Cancer With KrasG12D Mutation
- NCT03810651 · 28 participants · Early Phase 1
Pencil Beam Scanning in Patients With Renal Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI